- Magnolol Inhibits High Fructose-Induced Podocyte Inflammation via Downregulation of TKFC/Sp1/HDAC4/Notch1 Activation
Ziang Zhou et al, 2024, Pharmaceuticals CrossRef - Magnolol: Chemistry and biology
Jianwei Xu et al, 2023, Industrial Crops and Products CrossRef - Inflammasome Molecular Insights in Autoimmune Diseases
Monica Neamțu et al, 2024, Current Issues in Molecular Biology CrossRef - STATs, promising targets for the treatment of autoimmune and inflammatory diseases
Xinlian He et al, 2024, European Journal of Medicinal Chemistry CrossRef - Traditional Chinese medicine for the treatment of immune-related nephropathy: A review
Pu Jiang et al, 2024, Acta Pharmaceutica Sinica B CrossRef - The rich pharmacological activities of Magnolia officinalis and secondary effects based on significant intestinal contributions
Lin Niu et al, 2021, Journal of Ethnopharmacology CrossRef - 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice
Xuewei Li et al, 2022, BMC Nephrology CrossRef - Pyroptosis and its role in autoimmune skin disease
Yuanjun Yao et al, 2024, Experimental Dermatology CrossRef - Differential expression of the inflammasome complex genes in systemic lupus erythematosus
Heidi Lacerda Alves da Cruz et al, 2020, Immunogenetics CrossRef - Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals
Dantong Wu et al, 2021, Frontiers in Pharmacology CrossRef - Magnolol Ameliorates Behavioral Impairments and Neuropathology in a Transgenic Mouse Model of Alzheimer’s Disease
Yan-Fang Xian et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef